Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/49024 
Erscheinungsjahr: 
2011
Quellenangabe: 
[Journal:] Advances in Management & Applied Economics [ISSN:] 1792-7552 [Volume:] 1 [Issue:] 1 [Publisher:] International Scientific Press [Year:] 2011 [Pages:] 1-14
Verlag: 
International Scientific Press
Zusammenfassung: 
In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects of increased price competition due to the reform on the entry of new pharmaceutical products were studied. The results show that the reform did affect the entry behavior of generic manufacturers as they became more prone to enter new package sizes into the market after the reform, but also that there is considerable heterogeneity in entry behavior between different ATC-code groups for both brand name and generic products.
Schlagwörter: 
pharmaceutical industry
generic competition
generic drugs
brand name drugs
JEL: 
D80
D83
L65
I11
Dokumentart: 
Article

Datei(en):
Datei
Größe
167.76 kB





Publikationen in EconStor sind urheberrechtlich geschützt.